10-119029854-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_199461.4(NANOS1):c.53C>T(p.Pro18Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00118 in 1,231,014 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_199461.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NANOS1 | NM_199461.4 | c.53C>T | p.Pro18Leu | missense_variant | 1/1 | ENST00000425699.3 | NP_955631.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NANOS1 | ENST00000425699.3 | c.53C>T | p.Pro18Leu | missense_variant | 1/1 | 6 | NM_199461.4 | ENSP00000393275.1 |
Frequencies
GnomAD3 genomes AF: 0.000469 AC: 70AN: 149304Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00176 AC: 5AN: 2836Hom.: 0 AF XY: 0.00224 AC XY: 4AN XY: 1786
GnomAD4 exome AF: 0.00128 AC: 1386AN: 1081600Hom.: 2 Cov.: 30 AF XY: 0.00135 AC XY: 699AN XY: 518570
GnomAD4 genome AF: 0.000468 AC: 70AN: 149414Hom.: 0 Cov.: 32 AF XY: 0.000384 AC XY: 28AN XY: 72932
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2024 | The c.53C>T (p.P18L) alteration is located in exon 1 (coding exon 1) of the NANOS1 gene. This alteration results from a C to T substitution at nucleotide position 53, causing the proline (P) at amino acid position 18 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | NANOS1: PP2, BS1, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at